SARS-CoV-2 RNA, Influenza A/B, and RSV RNA, Qualitative NAAT : 39816

CVFRSV or 39816

Novel Coronavirus, nCOV, COVID-19, COVID 19, Flu A/B, Wuhan, Coronavirus

Includes: Influenza A RNA, Influenza B RNA,  RSV RNA, SARS CoV2 RNA 

Cold packs/pouches should be used if placing specimens in a lockbox for courier pick-up. Each COVID-19/Flu AB/RSV specimen transport vial that is submitted should be accompanied by its own separate requisition and transported in its own sealed bag.

Preferred  Specimen:
One nasopharyngeal swab collected in VCM or UTM

Alternate Specimen:
Nasal swab collected into VCM, UTM, or equivalent media.
 

Refrigerated.

Room temperature: 24 hours; Refrigerated: 7 days; Frozen: 30 days (-70 degrees Celsius)

Calcium alginate swabs, Cotton swabs in wooden shaft, Amies liquid or gel transport for bacterial cultures, Tubes with clot activator, Glass tubes, Snap-cap tubes, 3D printed swabs, Media with guanidine isothiocyanate (GITC) due to safety concerns, Specimen at room temperature for >24 hours, Throat and lower respiratory samples, Transport tube with the swab inverted.  Swab in saline.

Sunday - Saturday

1 day

This test has been authorized by the FDA under an Emergency Use Authorization (EUA) for use by authorized laboratories.

Influenza A RNA Not detected 
Influenza B RNA Not detected 
RSV RNA Not detected 
SARS CoV2 RNA Not detected 

SARS-CoV-2 RNA, Influenza A/B, and RSV RNA, Qualitative NAAT - SARS-CoV-2 RNA, Influenza A/B, and RSV RNA, Qualitative NAAT is a multitarget molecular test that aids in simultaneous qualitative detection and differentiation of SARS-CoV-2 (COVID-19), influenza A, influenza B, and respiratory syncytial virus (RSV) viral RNA. This test is intended to be performed on respiratory specimens collected from individuals suspected of respiratory viral infection consistent with COVID-19 or influenza or RSV by their healthcare provider. Clinical signs and symptoms of respiratory viral infection due to SARS-CoV-2, influenza, and RSV can be similar.